DiaDexus, a South San Francisco company that makes tests to detect cancer and cardiovascular disease, said it has raised $40 million in a fifth round of funding, according to VentureWire (sub required).

The company says the funding will take it to profitability next year. Baker Brothers Advisors and Scale Venture Partners led the investment. Other investors included Burrill & Co., and existing investors GlaxoSmithKline, Rho Ventures, Bain Capital’s Brookside Fund and Mosaix Ventures, the report said. The company previously raised $127.5 million over the last decade, including from a number of other investors.

(This story first posted 1/12)